VIM
ABBV icon

VELA Investment Management’s AbbVie ABBV Stock Holding History

VELA Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,000
Closed -$217K – 164
2026
Q1 		$217K Buy
+1,000
New +$222K 0.05% 167
2025
Q4 		– Sell
-5,000
Closed -$1.16M – 169
2025
Q3 		$1.16M Hold
5,000
– – 0.28% 108
2025
Q2 		$928K Buy
+5,000
New +$929K 0.25% 112

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

VELA Investment Management's ABBV Position: Q2 2026 in Review

VELA Investment Management reduced its AbbVie (ABBV) stake by 0.65% in Q2 2026, selling an estimated $3.44K and leaving 2,438 shares worth $613K. The position accounts for 0.13% of the portfolio, ranked #128.

VELA Investment Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.95M in Q1 2023. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • VELA Investment Management held 2,438 shares of AbbVie worth $613K as of Q2 2026.
  • VELA Investment Management sold 16 AbbVie shares in Q2 2026, an estimated $3.44K.
  • AbbVie made up 0.13% of VELA Investment Management's portfolio in Q2 2026, its #128 holding.
  • VELA Investment Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • VELA Investment Management's AbbVie position peaked at $2.95M in Q1 2023.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on VELA Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.